Skip to content
2000
Volume 20, Issue 6
  • ISSN: 1573-4013
  • E-ISSN: 2212-3881

Abstract

Introduction: This study focused on the formulation processing and antimicrobial activities of Origanum and Thyme essential oils (OEO) (TEO) and their nanoemulsions (OEON) (TEON) on gram-positive and gram-negative bacteria and yeast. Optimal nanoemulsion formulation and stability were achieved through balancing between requisite hydrophilic-lipophilic balance (rHLB) and surfactant concentration (Smix) of nanoemulsions. Methods: The smallest droplet sizes of OEON: (z -185.1 nm ± 0.85) and TEON (z -130.1 nm ± 0.60), were achieved by using 10 g/100 mL of OEO and TEO with 15 g/100 mL Smix at ultrasonication for 2 min with no phase separation. The size of nanoemulsion droplet and PDI was found to be influenced by HLB value, treatment time, and Smix concentration. Antimicrobial analyses, including a zone of inhibition, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and time-kill kinetics assay, were performed against , and . Results: The antimicrobial findings demonstrated that OEO exhibited higher antimicrobial activity compared to TEO (P<0.05). Meanwhile, the OEON and TEON substantially reduced the MIC and MBC values, compared to OEO and TEO against all tested microorganisms (P<0.05). Throughout the time-kill assay, was reduced by 5 log CFU/ml within 120 minutes, while S. cerevisiae and were eradicated after 60 and 120 minutes of incubation with OEON, respectively. Conclusion: In turn, TEON reduced by 5 log CFU/ml and by 4 log CFU/ml within 120 minutes, while was inhibited within the same time of incubation with TEON. The nanoemulsion formulations of OEO and TEO considerably enhanced the antimicrobial properties, which provides a promising alternative plant-derived antimicrobial for pharmaceuticals and food applications.

Loading

Article metrics loading...

/content/journals/cnf/10.2174/1573401319666230914140953
2024-07-01
2025-09-17
Loading full text...

Full text loading...

/content/journals/cnf/10.2174/1573401319666230914140953
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test